PAA 4.88% 19.5¢ pharmaust limited

Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-35

  1. 55 Posts.
    lightbulb Created with Sketch. 2
    Great news indeed! I do recall however we were supposed to get FDA feedback - anyone know anything about this?
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.